Skip to main content

Table 3 Clinical outcomes in patients undergoing post-CMR interventiona

From: High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion

Parameter All patients (n = 24) Only central venous access placement (n = 9) SVC reconstruction (n = 9) IVC reconstruction (n = 6)
Pre-intervention Creatininea 4.0 (3.5) 4.6 (4.0) 4.6 (4.0) 2.3 (1.4)
Post-intervention Creatininea 3.6 (2.9) 4.1 (3.7) 4.0 (2.8) 2.1 (1.2)
Pre-intervention eGFRa 30.9 (26.0) 31.8 (33.5) 21.8 (13.7) 43.2 (25.9)
Post-intervention eGFRa 31.0 (23.5) 31.4 (28.0) 21.4 (12.4) 44.7 (25.6)
Days from MRI to interventional procedureb 3.5 (2.0–7.0) 2.0 (0.5–4.0) 7.0 (2.5–28.5) 3.0 (1.5–16.3)
Received iodine based contrast mediac 15 (63) 1 (11) 9 (100) 5 (83)
Volume of iodine based contrast media (mL)b 12.5 (0–40.0) 0 (0–0) 30.0 (17.5–60.0) 42.5 (7.5–52.5)
Fluoroscopy time (minutes)b 10.0 (1.9–25.1) 1.4 (0.3–2.4) 16.0 (7.3–29.0) 23.1 (10.1–49.0)
Air Kerma (mGy)b 341.0 (20.0–1337.0)d 15.0 (9.5–29.7) 450.5 (346.8–1476.5)d 1479.4 (610.8–2283.0)
Dose area product (cGy/cm2)b 4590.2 (423.1–20,302.1)d 432.1 (238.3–858.9) 9806.8 (5736.7–18,852.4)d 44,273.8 (3485.1–59,494.6)
  1. aData are mean, with standard deviation in parenthesis
  2. bData are median, with interquartile range in parenthesis
  3. cData are number of patients, with percentages in parenthesis. Percentages were rounded
  4. dThe air kerma and dose area product could not be extracted from the chart of one patient undergoing an SVC reconstruction procedure